Targeting pharmacy price opportunists and cost outliers that add little-to-no value clinically and increase overall drug spend promotes appropriate, evidence-based care while addressing leakage.
Price Opportunists
Many of these products are not considered medically necessary compared to readily-available, clinically-appropriate, and more cost-effective alternatives.
To find out more about why deploying tactics that identify and determine appropriateness of price opportunists and outliers is critical, download our drug mix management information.
